Highest cost Pharmaceuticals/Infusions – $100 billion is spent in the US by self-insured employers/HMOs and unions on big ticket ($40,000 plus/year) pills, injections and infusions. This sector is the most inflationary segment of US healthcare as we move from treatment to prevention or eradication of a myriad of chronic diseases

The problem confronting US employers and unions are the very inflated prices for pills/injections/infusions – NMS’s international pricing is the solution.

The US has the highest drug and infusion prices in the world. Every US resident suffers, especially the 27 million uninsured and the 43% of under 65 patients with high deductible plans. Even the well insured have yearly increasing copays and deductibles. NMS-TMPB pricing is the solution.